ESMO LUNG CANCER
Online Only

Pulmonary and Respiratory Medicine

Lung Cancer (2027)

Editor in Chief: Rolf Stahel, Zurich, Switzerland
Organizational Affiliations: European Society for Medical Oncology, ETOP IBCSG Partners Foundation, British Thoracic Oncology Group

Lung Cancer is an international publication covering the clinical, translational and basic science of malignancies of the lung and chest region.Original research articles, early reports, review articles and editorials covering the prevention, epidemiology and etiology, basic biology, pathology, clinical assessment, surgery, chemotherapy, radiotherapy, combined treatment modalities, other treatment modalities and outcomes of lung cancer are all welcome. Letters to the journals are also welcomed although authors should be aware that the majority will be published online only. Early reports should briefly describe the initial results of a research topic and will be expedited through peer-review.Manuscripts describing studies on cell lines will only be considered if the data compares at least two types of distinct cell lines and the results have general implications on the understanding of the biology of chest tumours. Authors of studies on cell lines must also agree to make freely available to other researchers any of the cells, clones of cells, or DNA or antibodies, etc, that were used in the research reported and that are not available from commercial suppliers.

Global Print Circulation
Online Only
Avg. Global Monthly Visits
16,260
Avg. Global Monthly Unique Visitors
11,277
Avg. Global Monthly Page Views
27,697
Avg. Global eTOC Distribution
2,536
Circulation updated on 1st October 2026, based on 12-month monthly average October 2025-September 2026, eTOC Metrics: 12 Month Average of eTOC sends - October 2025 to September 2026, Monthly average web metrics based on the period of October 2025 to September 2026